MedPath

Smerud Medical Research International AS

🇳🇴Norway
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 3
1 (33.3%)

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

Phase 3
Conditions
Pain
Osteoarthritis
Interventions
First Posted Date
2009-08-07
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
300
Registration Number
NCT00954629
Locations
🇫🇮

Site in Helsinki, Helsinki, Finland

🇫🇮

Site at Kuopio, Kuopio, Finland

🇫🇮

Site in Turku, Turku, Finland

and more 11 locations

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Phase 2
Conditions
Stump Pain
Interventions
Drug: Placebo
First Posted Date
2008-12-08
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
150
Registration Number
NCT00804375
Locations
🇩🇰

Site in Herlev, Herlev, Denmark

🇩🇰

Site in Hvidovre, Hvidovre, Denmark

🇩🇰

Site in Århus, Århus, Denmark

and more 16 locations

Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.

Phase 2
Conditions
Renal Transplant
Interventions
Drug: Placebo
First Posted Date
2007-01-18
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
130
Registration Number
NCT00423384
Locations
🇳🇴

Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway

News

No news found
© Copyright 2025. All Rights Reserved by MedPath